[ Price : $8.95]
FDA releases five guidances relating to expanding the 510(k) program that the Safety and Performance Based Pathway.[ Price : $8.95]
FDA solicits comments on abuse-deterrent formulations for prescription stimulants.[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension for it MedSun adverse event program for medical...[ Price : $8.95]
Federal Register notice: FDA posts a draft guidance entitled Safer Technologies Program for Medical Devices, a new, voluntary prog...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Citizen Petitions and Petitions for Stay of Action Subject ...[ Price : $8.95]
FDA updates its list of drugs for which the agency has received a reference-listed drug access inquiry.[ Price : $8.95]
House Speaker Nancy Pelosi releases her initial legislation to lower drug prices in ways she hopes will attract support from Presi...[ Price : $8.95]
FDA grants Genentech a breakthrough therapy designation for Gazyva (obinutuzumab) for adults with lupus nephritis.